Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine for pain after radical cystectomy
NCT02438852Phase 3Withdrawn
- Sponsor
- University of Southern California
- Start
- Feb 2019
- Primary completion
- Feb 2021
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 3 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by University of Southern California. Planned start Feb 2019; status: withdrawn.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02438852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02438852.